Alcohol interaction trial enhanced with responsive, collaborative approach, says CRO

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/OlegEvseev)
(Image: Getty/OlegEvseev)

Related tags Clinical trial Contract research organization Clinical research

Vince & Associates Clinical Research is conducting a Phase Ib alcohol interaction study of Amygdala Neurosciences’ ANS-6637 for the potential treatment of substance abuse.

An Altasciences company, Vince & Associates Clinical Research is a contract research organization (CRO) based in Overland Park, KS.

The proof-of-concept, dose-ranging study will evaluate the safety of the co-administration of ascending doses of ANS-6637 and ethanol in healthy male alcohol drinkers, according to the company.

Amygdala Neurosciences Inc. acquired ANS-6637 (previously GS-6637) from Gilead Sciences, Inc. earlier this year. Its potential clinical indication is the treatment of substance abuse, including alcohol and cocaine dependence.

As for the challenges of conducting the trial, Bradley Vince, D.O., CEO and medical director at Vince & Associates Clinical Research told us the study requires “significant investigator and clinical operations staffing secondary to the necessary safety monitoring and medical hypervigilance​.”

Additionally, recruitment will also be a challenge – as it is across the industry – though specifically, the alcohol interaction trial will require recruitment of qualified volunteers that meet protocol specified eligibility with respect to alcohol consumption history, Vince explained.

It is imperative to utilize a CRO with significant expertise in special populations as well as depth in the Investigator staff secondary to the extensive medical procedures required in alcohol interaction trials​,” he added.

Further, a responsive and collaborative approach by the sponsor with respect to dose escalations further enhances the successful study conduct of these complex clinical trials​,” said Vince.

The CRO has completed five of six dosing cohorts.

Related topics Clinical Development Phase I-II

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more